Terlipressin in Hepatorenal Syndrome

The use of terlipressin during living donor liver transplantation: Effects on systemic and splanchnic hemodynamics and renal function*

(2011) Ahmed Mukhtar et al.   CRITICAL CARE MEDICINE

The effects of vasopressin and its analogues on the liver and its disorders in the critically ill

(2010) Pierre Asfar et al.   Current Opinion in Critical Care

Terlipressin therapy for reversal of type 1 hepatorenal syndrome: A meta-analysis of randomized controlled trials

(2010) Sashidhar V Sagi et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Cutaneous Necrosis Secondary to Terlipressin Therapy

(2009) C Posada et al.   ACTA DERMATO-VENEREOLOGICA

Terlipressin for Hepatorenal Syndrome: Continuous Infusion as an Alternative to IV Bolus Administration

(2009) Alexander L. Gerbes et al.   GASTROENTEROLOGY

Treatment of Hepatorenal Syndrome

(2009) Tyree H Kiser et al.   PHARMACOTHERAPY

An Open Label, Pilot, Randomized Controlled Trial of NoradrenalineVersusTerlipressin in the Treatment of Type 1 Hepatorenal Syndrome and Predictors of Response

(2008) Praveen Sharma et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Terlipressin and Albumin vs Albumin in Patients With Cirrhosis and Hepatorenal Syndrome: A Randomized Study

(2008) Marta Martín–Llahí et al.   GASTROENTEROLOGY

A Randomized, Prospective, Double-Blind, Placebo-Controlled Trial of Terlipressin for Type 1 Hepatorenal Syndrome

(2008) Arun J. Sanyal et al.   GASTROENTEROLOGY

Terlipressin infusion induces ischemia of breast skin in a cirrothic patient with hepatorenal syndrome

(2007) A. Di Micoli et al.   DIGESTIVE AND LIVER DISEASE